SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a U.S.-based global pioneer fueling the future of sustainable, plant-based and fruit-based foods and beverages, today announced financial results for the second quarter ended July 2, 2022.
All amounts are expressed in U.S. dollars and results are reported in accordance with U.S. GAAP, except where specifically noted.
Second quarter 2022 highlights:
“Second quarter results were excellent, driven by strong revenue growth and our highest Adjusted EBITDA in company history2. Revenues were up 20.4%, and Adjusted EBITDA increased 38.4% as we continued to leverage the power of our platform to accelerate growth and increase profitability,” said Joe Ennen, Chief Executive Officer. Plant-Based revenues surged 31.0% to $145.9 million, a new quarterly record reflecting the strength of our oat-based offering and double-digit increases in volume, mix and pricing. We saw growth in nearly every customer, every channel, every product type and in every go-to-market business, reflecting the strength of our SunOpta value proposition. In Fruit-Based, revenues increased 7.4% due to demand for fruit snacks and smoothie bowls along with higher price realization in frozen fruit. “While the macro environment remains challenging, we have been able to offset the majority of inflation with pricing and our productivity initiatives continue to gain traction. The actions we have taken over the past several years to optimize our product portfolio, streamline operations and aggressively expand capacity are driving significant and sustainable momentum across our business. With a leading share in the fastest growing categories and a strong pipeline of innovation, we are well positioned to realize our vision of Fueling the Future of Food. Our increased outlook for 2022 reflects the strength of recent results, and more importantly our confidence in our ability to continue delivering significant growth and increasing value for shareholders.”
Second Quarter 2022 Results
Revenues of $243.5 million for the second quarter of 2022 increased 20.4% compared to the second quarter of 2021 driven by 31.0% growth in Plant-Based Foods and Beverages and 7.4% growth in Fruit-Based Foods and Beverages. The increase in revenues reflected a 12.2% increase in pricing along with an 8.2% increase in volume/mix.
The Plant-Based Foods and Beverages segment generated revenues of $145.9 million, an increase of 31.0% compared to $111.4 million in the second quarter of 2021. Pricing increased 13.7% driven by actions to offset inflationary pressures, together with the pass-through effect of higher sunflower commodity pricing. Volume/mix was up 17.3%, reflecting growth in oat-based offerings, other plant-based beverages and teas.
The Fruit-Based Foods and Beverages segment generated revenues of $97.6 million, an increase of 7.4% compared to $90.9 million in the second quarter of 2021. Pricing increased 10.4% reflecting actions to offset inflationary pressures, while volume/mix declined 3.0% due to lower demand for frozen fruit and our portfolio rationalization efforts, offset by strong demand for fruit snacks and smoothie bowls.
Gross profit was $34.9 million for the second quarter, an increase of $8.6 million compared to $26.3 million in the prior year period. As a percentage of revenues, gross profit margin was 14.3% compared to 13.0% in the second quarter of 2021, an increase of 130 basis points. Gross profit in the Plant-Based Foods and Beverages segment increased $4.0 million to $23.9 million, while gross margin declined 150 basis points to 16.4% primarily due to the 215-basis point dilutive effect of pass-through pricing to recover cost inflation. Gross profit in the Fruit-Based Foods and Beverages segment increased by $4.5 million to $11.0 million and gross margin increased 410 basis points to 11.2% despite a 70-basis point impact from the dilutive effect of pass-through pricing to offset commodity cost inflation. Excluding the pricing effect, Fruit-Based gross margin benefited from portfolio rationalization and manufacturing consolidation.
Segment operating income¹ was $8.1 million, or 3.3% of revenues in the second quarter of 2022, compared to segment operating income of $1.7 million, or 0.9% of revenues in the second quarter of 2021. The increase in segment operating income was due to higher gross profit, partially offset by a $1.6 million increase in SG&A expenses due to higher incentive accruals partially offset by employee compensation costs related to headcount reductions in frozen fruit operations, lower business development expenses and unfavorable foreign exchange impact related to Mexican operations.
Adjusted EBITDA¹ was $22.3 million or 9.2% of revenues in the second quarter of 2022, compared to $16.1 million or 8.0% of revenues in the second quarter of 2021.
Earnings attributable to common shareholders for the second quarter of 2022 was $0.9 million, or $0.01 per diluted common share, compared to a loss of $1.7 million, or ($0.02) per diluted common share during the second quarter of 2021.
Adjusted earnings¹ in the second quarter of 2022 was $3.5 million or $0.03 per common share, compared to adjusted earnings of $0.1 million or $0.00 per common share in the second quarter of 2021.
Please refer to the discussion and table below under “Non-GAAP Measures”.
Balance Sheet and Cash Flow
As of July 2, 2022, SunOpta had total assets of $843.9 million and total debt of $296.5 million compared to total assets of $755.1 million and total debt of $224.6 million at year end fiscal 2021. During the second quarter of 2022, cash used in operating activities was $2.5 million compared to cash used in operating activities of $39.1 million during the second quarter of 2021. Investing activities of continuing operations consumed $34.1 million of cash during the second quarter of 2022 versus $32.4 million in the prior year, primarily driven by the new plant construction in Midlothian, Texas which is expected to come online in late 2022.
2022 Outlook3
We are raising our previously provided outlook for fiscal 2022, including:
($ millions) |
| Prior |
| Revised | ||
Revenue | $ | 890 - 930 | $ | 930 - 960 | ||
Adj. EBITDA | 67 - 75 | 72 - 78 | ||||
Revenue growth | 10% - 14% | 14% - 18% | ||||
Adj. EBITDA growth | 10% - 24% | 19% - 28% |
Conference Call
SunOpta plans to host a conference call at 5:00 P.M. Eastern time on Wednesday, August 10, 2022, to discuss the second quarter financial results. After opening remarks, there will be a question and answer period. Investors interested in listening the live webcast can access a link on SunOpta's website at www.sunopta.com under the "Investor Relations" section or directly here. A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company's website. This call may be accessed with the toll free dial-in number dial (888) 440-4182 or International dial-in number (646) 960-0653 using Conference ID: 8338433.
¹ See discussion of non-GAAP measures
2 Excludes the impact of the 2020 divestiture of our global ingredients business
3 The Company has included certain forward-looking statements about the future financial performance that include non-GAAP financial measures, including Adjusted EBITDA. These non–GAAP financial measures are derived by excluding certain amounts, expenses or income, from the corresponding financial measures determined in accordance with GAAP. The determination of the amounts that are excluded from these non-GAAP financial measures is a matter of management judgment and depends upon, among other factors, the nature of the underlying expense or income amounts recognized in a given period. We are unable to present a quantitative reconciliation of the aforementioned forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures because management cannot reliably predict all of the necessary components of such GAAP measures. Historically, management has excluded the following items from certain of these non-GAAP measures, and such items may also be excluded in future periods and could be significant amounts.
About SunOpta Inc.
SunOpta (Nasdaq:STKL) (TSX:SOY) is a U.S.-based, global pioneer fueling the future of sustainable, plant-based and fruit-based food and beverages. Founded nearly 50 years ago, SunOpta manufactures natural, organic and specialty products sold through retail and foodservice channels. SunOpta operates as a manufacturer for leading natural and private label brands, and also proudly produces its own brands, including SOWN®, Dream™, WestSoy™ and Sunrise Growers™. For more information, visit www.sunopta.com and LinkedIn.
Forward-Looking Statements
Certain statements included in this press release may be considered "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, which are based on information available to us on the date of this release. These forward-looking statements include, but are not limited to, our belief that our productivity initiatives will continue to gain traction and that we will continue to deliver significant growth and increasing value for shareholders, when we expect our new plant in Midlothian, Texas to come online and our anticipated revenue, adjusted EBITDA, revenue growth and adjusted EBITDA growth for fiscal 2022. Generally, forward-looking statements do not relate strictly to historical or current facts and are typically accompanied by words such as “continue”, “expect”, “believe”, “anticipate”, “estimates”, “can”, “will”, “target”, "should", "would", "plans", "becoming", "intend", "confident", "may", "project", "potential", "intention", "might", "predict", “outlook”, “budget”, “forecast” or other similar terms and phrases intended to identify these forward-looking statements. Forward-looking statements are based on information available to the Company on the date of this release and are based on estimates and assumptions made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments including, but not limited to, the Company’s actual financial results; uninterrupted operations and service levels to our customers ; current and anticipated customer demand for the Company’s; general economic conditions; continued consumer interest in health and wellness; the Company’s ability to maintain product pricing levels; planned facility and operational expansions, closures and divestitures; cost rationalization and product development initiatives; alternative potential uses for the Company’s capital resources; portfolio optimization and productivity efforts; the sustainability of the Company’s sales pipeline; the Company’s expectations regarding commodity pricing, margins and hedging results; improved availability and field prices for fruit; procurement and logistics savings; freight lane cost reductions; yield and throughput enhancements; and labor cost reductions. Whether actual timing and results will agree with expectations and predictions of the Company is subject to many risks and uncertainties including, but not limited to, potential loss of suppliers and customers as well as supply chain, logistics and other disruptions whether resulting from or related to COVID-19 or other factors; unexpected issues or delays with the Company’s structural improvements and automation investments; failure or inability to implement portfolio changes, process improvements, go-to-market improvements and process sustainability strategies in a timely manner; changes in the level of capital investment; local and global political and economic conditions; consumer spending patterns and changes in market trends; decreases in customer demand; delayed or unsuccessful product development efforts; potential product recalls; working capital management; availability and pricing of raw materials and supplies; ability to hire and/or retain qualified personnel at current compensation rates; potential covenant breaches under the Company’s credit facilities; and other risks described from time to time under "Risk Factors" in the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q (available at www.sec.gov). Consequently, all forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized. The Company undertakes no obligation to publicly correct or update the forward-looking statements in this document, in other documents, or on its website to reflect future events or circumstances, except as may be required under applicable securities laws.
SunOpta Inc. | |||||||||||
Consolidated Statements of Operations | |||||||||||
For the quarters and two quarters ended July 2, 2022 and July 3, 2021 | |||||||||||
(Unaudited) | |||||||||||
(All dollar amounts expressed in thousands of U.S. dollars, except per share amounts) | |||||||||||
|
|
|
|
|
|
|
| ||||
|
|
|
| Quarter ended | Two quarters ended | ||||||
|
|
|
| July 2, 2022 | July 3, 2021 | July 2, 2022 | July 3, 2021 | ||||
|
|
|
| $ | $ | $ | $ | ||||
|
|
|
|
|
|
|
| ||||
Revenues | 243,531 |
| 202,273 |
| 483,704 |
| 409,913 |
| |||
|
|
|
|
|
|
|
| ||||
Cost of goods sold | 208,633 |
| 175,937 |
| 420,815 |
| 353,588 |
| |||
|
|
|
|
|
|
|
| ||||
Gross profit | 34,898 |
| 26,336 |
| 62,889 |
| 56,325 |
| |||
|
|
|
|
|
|
|
| ||||
Selling, general and administrative expenses | 24,304 |
| 22,720 |
| 46,239 |
| 43,594 |
| |||
Intangible asset amortization | 2,612 |
| 2,532 |
| 5,224 |
| 4,726 |
| |||
Other expense, net | 1,540 |
| 4,661 |
| 1,827 |
| 6,276 |
| |||
Foreign exchange loss (gain) | (127 | ) | (639 | ) | (599 | ) | 197 |
| |||
|
|
|
|
|
|
|
| ||||
Earnings (loss) from continuing operations before the following | 6,569 |
| (2,938 | ) | 10,198 |
| 1,532 |
| |||
|
|
|
|
|
|
|
| ||||
Interest expense, net | 3,132 |
| 1,631 |
| 5,662 |
| 3,291 |
| |||
|
|
|
|
|
|
|
| ||||
Earnings (loss) from continuing operations before income taxes | 3,437 |
| (4,569 | ) | 4,536 |
| (1,759 | ) | |||
|
|
|
|
|
|
|
| ||||
Income tax expense (benefit) | 939 |
| (3,651 | ) | 1,384 |
| (2,513 | ) | |||
|
|
|
|
|
|
|
| ||||
Earnings (loss) from continuing operations | 2,498 |
| (918 | ) | 3,152 |
| 754 |
| |||
Earnings (loss) from discontinued operations | (814 | ) | - |
| 2,752 |
| - |
| |||
Net earnings (loss) | 1,684 |
| (918 | ) | 5,904 |
| 754 |
| |||
|
|
|
|
|
|
|
| ||||
Dividends and accretion on preferred stock | (760 | ) | (744 | ) | (1,515 | ) | (2,697 | ) | |||
|
|
|
|
|
|
|
| ||||
Earnings (loss) attributable to common shareholders | 924 |
| (1,662 | ) | 4,389 |
| (1,943 | ) | |||
|
|
|
|
|
|
|
| ||||
Basic and diluted earnings (loss) per share |
|
|
|
| |||||||
| From continuing operations | 0.02 |
| (0.02 | ) | 0.02 |
| (0.02 | ) | ||
| From discontinued operations | (0.01 | ) | - |
| 0.03 |
| - |
| ||
Basic and diluted earnings (loss) per share | 0.01 |
| (0.02 | ) | 0.04 |
| (0.02 | ) | |||
|
|
|
|
|
|
|
| ||||
Weighted-average common shares outstanding (000s) |
|
|
|
| |||||||
| Basic | 107,622 |
| 105,676 |
| 107,510 |
| 100,898 |
| ||
| Diluted | 108,667 |
| 105,676 |
| 108,495 |
| 100,898 |
|
SunOpta Inc. | |||||||
Consolidated Balance Sheets | |||||||
As at July 2, 2022 and January 1, 2022 | |||||||
(Unaudited) | |||||||
(All dollar amounts expressed in thousands of U.S. dollars) | |||||||
|
|
|
|
|
| ||
|
|
|
| July 2, 2022 | January 1, 2022 | ||
|
|
|
| $ | $ | ||
|
|
|
|
|
| ||
ASSETS |
|
| |||||
Current assets |
|
| |||||
| Cash and cash equivalents | 553 |
| 227 |
| ||
| Accounts receivable | 83,804 |
| 84,702 |
| ||
| Inventories | 261,899 |
| 220,143 |
| ||
| Prepaid expenses and other current assets | 17,493 |
| 16,638 |
| ||
| Income taxes recoverable | 9,861 |
| 8,259 |
| ||
| Assets held for sale | 11,591 |
| - |
| ||
Total current assets | 385,201 |
| 329,969 |
| |||
|
|
|
|
|
| ||
Property, plant and equipment, net | 264,690 |
| 219,537 |
| |||
Operating lease right-of-use assets | 40,990 |
| 47,245 |
| |||
Intangible assets, net | 143,216 |
| 148,440 |
| |||
Goodwill | 3,998 |
| 3,998 |
| |||
Other assets | 5,827 |
| 5,930 |
| |||
|
|
|
|
|
| ||
Total assets | 843,922 |
| 755,119 |
| |||
|
|
|
|
|
| ||
LIABILITIES |
|
| |||||
Current liabilities |
|
| |||||
| Accounts payable and accrued liabilities | 143,102 |
| 121,430 |
| ||
| Income taxes payable | 711 |
| - |
| ||
| Current portion of long-term debt | 23,055 |
| 9,760 |
| ||
| Current portion of operating lease liabilities | 9,933 |
| 12,203 |
| ||
Total current liabilities | 176,801 |
| 143,393 |
| |||
|
|
|
|
|
| ||
Long-term debt | 273,493 |
| 214,843 |
| |||
Operating lease liabilities | 37,084 |
| 39,028 |
| |||
Long-term liabilities | - |
| 2,241 |
| |||
Deferred income taxes | 13,510 |
| 22,485 |
| |||
Total liabilities | 500,888 |
| 421,990 |
| |||
|
|
|
|
|
| ||
Series B-1 preferred stock | 28,442 |
| 28,145 |
| |||
|
|
|
|
|
| ||
SHAREHOLDERS' EQUITY |
|
| |||||
Common shares | 438,668 |
| 436,463 |
| |||
Additional paid-in capital | 26,254 |
| 23,240 |
| |||
Accumulated deficit | (151,693 | ) | (156,082 | ) | |||
Accumulated other comprehensive income | 1,363 |
| 1,363 |
| |||
Total shareholders' equity | 314,592 |
| 304,984 |
| |||
|
|
|
|
|
| ||
Total liabilities and shareholders' equity | 843,922 |
| 755,119 |
|
SunOpta Inc. | |||||||||||
Consolidated Statements of Cash Flows | |||||||||||
For the quarters and two quarters ended July 2, 2022 and July 3, 2021 | |||||||||||
(Unaudited) | |||||||||||
(Expressed in thousands of U.S. dollars) | |||||||||||
|
|
|
|
|
|
|
| ||||
|
|
|
| Quarter ended | Two quarters ended | ||||||
|
|
|
| July 2, 2022 | July 3, 2021 | July 2, 2022 | July 3, 2021 | ||||
|
|
|
| $ | $ | $ | $ | ||||
|
|
|
|
|
|
|
| ||||
CASH PROVIDED BY (USED IN) |
|
|
|
| |||||||
Operating activities |
|
|
|
| |||||||
Net earnings (loss) | 1,684 |
| (918 | ) | 5,904 |
| 754 |
| |||
Earnings (loss) from discontinued operations | (814 | ) | - |
| 2,752 |
| - |
| |||
Earnings (loss) from continuing operations | 2,498 |
| (918 | ) | 3,152 |
| 754 |
| |||
Items not affecting cash: |
|
|
|
| |||||||
| Depreciation and amortization | 9,372 |
| 8,910 |
| 18,785 |
| 16,953 |
| ||
| Amortization of debt issuance costs | 396 |
| 349 |
| 771 |
| 634 |
| ||
| Deferred income taxes | 2,128 |
| (4,331 | ) | 2,208 |
| (3,494 | ) | ||
| Stock-based compensation | 3,970 |
| 4,370 |
| 5,599 |
| 8,343 |
| ||
| Impairment of long-lived assets | - |
| 2,962 |
| - |
| 2,962 |
| ||
| Other | 1,634 |
| (167 | ) | 1,745 |
| (336 | ) | ||
| Changes in operating assets and liabilities | (22,452 | ) | (50,322 | ) | (19,171 | ) | (71,978 | ) | ||
Net cash provided by (used in) operating activities of continuing operations | (2,454 | ) | (39,147 | ) | 13,089 |
| (46,162 | ) | |||
|
|
|
|
|
|
|
| ||||
Investing activities |
|
|
|
| |||||||
Additions to property, plant and equipment | (37,038 | ) | (7,306 | ) | (62,760 | ) | (16,603 | ) | |||
Proceeds from sale of assets | 2,978 |
| - |
| 4,182 |
| 1,350 |
| |||
Additions to intangible assets | - |
| (25,073 | ) | - |
| (25,073 | ) | |||
Net cash used in investing activities of continuing operations | (34,060 | ) | (32,379 | ) | (58,578 | ) | (40,326 | ) | |||
Net cash used in investing activities of discontinued operations | (6,324 | ) | - |
| (6,324 | ) | (13,380 | ) | |||
Net cash used in investing activities | (40,384 | ) | (32,379 | ) | (64,902 | ) | (53,706 | ) | |||
|
|
|
|
|
|
|
| ||||
Financing activities |
|
|
|
| |||||||
Increase in borrowings under revolving credit facilities | 31,067 |
| 70,244 |
| 20,762 |
| 111,829 |
| |||
Borrowings of long-term debt | 18,206 |
| 4,155 |
| 41,103 |
| 4,641 |
| |||
Repayment of long-term debt | (5,174 | ) | (5,855 | ) | (7,569 | ) | (9,940 | ) | |||
Payment of debt issuance costs | (53 | ) | (543 | ) | (559 | ) | (2,371 | ) | |||
Proceeds from the exercise of stock options and employee share purchases | 341 |
| 4,550 |
| 591 |
| 7,190 |
| |||
Payment of withholding taxes on stock-based awards | (882 | ) | (666 | ) | (971 | ) | (6,737 | ) | |||
Payment of cash dividends on preferred stock | (609 | ) | (609 | ) | (1,218 | ) | (4,029 | ) | |||
Payment of share issuance costs | - |
| (25 | ) | - |
| (287 | ) | |||
Net cash provided by financing activities of continuing operations | 42,896 |
| 71,251 |
| 52,139 |
| 100,296 |
| |||
Net cash used in financing activities of discontinued operations | - |
| - |
| - |
| (200 | ) | |||
Net cash provided by financing activities | 42,896 |
| 71,251 |
| 52,139 |
| 100,096 |
| |||
|
|
|
|
|
|
|
| ||||
Increase (decrease) in cash and cash equivalents in the period | 58 |
| (275 | ) | 326 |
| 228 |
| |||
Cash and cash equivalent, beginning of the period | 495 |
| 754 |
| 227 |
| 251 |
| |||
Cash and cash equivalents, end of the period | 553 |
| 479 |
| 553 |
| 479 |
|
SunOpta Inc. | |||||||||||
Segmented Information | |||||||||||
For the quarters and two quarters ended July 2, 2022 and July 3, 2021 | |||||||||||
Unaudited | |||||||||||
(Expressed in thousands of U.S. dollars) | |||||||||||
|
|
|
|
|
|
|
| ||||
|
|
|
| Quarter ended | Two quarters ended | ||||||
|
|
|
| July 2, 2022 | July 3, 2021 | July 2, 2022 | July 3, 2021 | ||||
|
|
|
| $ | $ | $ | $ | ||||
Segment revenues from external customers: |
|
|
|
| |||||||
| Plant-Based Foods and Beverages | 145,912 |
| 111,359 |
| 281,423 |
| 230,810 |
| ||
| Fruit-Based Foods and Beverages | 97,619 |
| 90,914 |
| 202,281 |
| 179,103 |
| ||
|
| Total segment revenues from external customers | 243,531 |
| 202,273 |
| 483,704 |
| 409,913 |
| |
|
|
|
|
|
| ||||||
Segment gross profit: |
|
|
|
| |||||||
| Plant-Based Foods and Beverages | 23,940 |
| 19,896 |
| 43,920 |
| 43,054 |
| ||
| Fruit-Based Foods and Beverages | 10,958 |
| 6,440 |
| 18,969 |
| 13,271 |
| ||
|
| Total segment gross profit | 34,898 |
| 26,336 |
| 62,889 |
| 56,325 |
| |
|
|
|
|
|
|
|
| ||||
Segment operating income (loss): |
|
|
|
| |||||||
| Plant-Based Foods and Beverages | 12,196 |
| 8,641 |
| 20,292 |
| 21,958 |
| ||
| Fruit-Based Foods and Beverages | 3,211 |
| (1,447 | ) | 3,995 |
| (3,341 | ) | ||
| Corporate Services | (7,298 | ) | (5,471 | ) | (12,262 | ) | (10,809 | ) | ||
|
| Total segment operating income | 8,109 |
| 1,723 |
| 12,025 |
| 7,808 |
| |
|
|
|
|
|
|
|
| ||||
Segment gross profit percentage: |
|
|
|
| |||||||
| Plant-Based Foods and Beverages | 16.4 | % | 17.9 | % | 15.6 | % | 18.7 | % | ||
| Fruit-Based Foods and Beverages | 11.2 | % | 7.1 | % | 9.4 | % | 7.4 | % | ||
|
| Total segment gross profit percentage | 14.3 | % | 13.0 | % | 13.0 | % | 13.7 | % | |
|
|
|
|
|
|
|
| ||||
Segment operating income (loss) percentage: |
|
|
|
| |||||||
| Plant-Based Foods and Beverages | 8.4 | % | 7.8 | % | 7.2 | % | 9.5 | % | ||
| Fruit-Based Foods and Beverages | 3.3 | % | -1.6 | % | 2.0 | % | -1.9 | % | ||
|
| Total segment operating income percentage | 3.3 | % | 0.9 | % | 2.5 | % | 1.9 | % |
Non-GAAP Measures
In addition to reporting financial results in accordance with U.S. GAAP, the Company provides additional information about its operating results regarding segment operating income, adjusted earnings and adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”), which are not measures in accordance with U.S. GAAP. The Company believes that segment operating income, adjusted earnings and adjusted EBITDA assist investors in comparing performance across reporting periods on a consistent basis by excluding items that management believes are not indicative of its operating performance. The non-GAAP measures of segment operating income, adjusted earnings and adjusted EBITDA should not be considered in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP.
In order to evaluate its results of operations, the Company uses certain other non-GAAP measures that it believes enhance an investor’s ability to derive meaningful period-over-period comparisons and trends from the results of operations. In particular, the Company excludes specific items from its reported results that due to their nature or size, it does not expect to occur as part of its normal business on a regular basis. These items are identified in the tables below. These non-GAAP measures are presented solely to allow investors to more fully assess the Company’s results of operations and should not be considered in isolation of, or as substitutes for, an analysis of the Company’s results as reported under U.S. GAAP.
Adjusted Earnings
When assessing its financial performance, the Company uses an internal measure that excludes charges and gains that it believes are not reflective of normal operations. This information is provided to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Adjusted earnings and adjusted earnings per diluted share should not be considered in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP.
The following is a tabular presentation of adjusted earnings and adjusted earnings per diluted share, including a reconciliation from earnings from continuing operations, which the Company believes to be the most directly comparable U.S. GAAP financial measure.
|
|
|
|
|
|
|
|
|
| |||
|
|
|
|
| July 2, 2022 |
| July 3, 2021 | |||||
|
|
|
|
|
| Per Share |
|
| Per Share | |||
| For the quarter ended | $ | $ |
| $ | $ | ||||||
| Earnings (loss) from continuing operations | 2,498 |
|
|
| (918 | ) |
| ||||
| Dividends and accretion on preferred stock | (760 | ) |
|
| (744 | ) |
| ||||
| Earnings (loss) from continuing operations attributable to common shareholders | 1,738 |
| 0.02 |
| (1,662 | ) | (0.02 | ) | |||
| Adjusted for: |
|
|
|
|
| ||||||
|
| Facility closure costs(a) | 1,287 |
|
|
| - |
|
| |||
|
| Business development costs(b) | 616 |
|
|
| 1,434 |
|
| |||
|
| Start-up costs(c) | 281 |
|
|
| - |
|
| |||
|
| Costs related to exit from fruit ingredient processing facility(d) | - |
|
|
| 4,123 |
|
| |||
|
| Other(e) | 253 |
|
|
| 247 |
|
| |||
|
| Net income tax effect(f) | (640 | ) |
|
| (4,022 | ) |
| |||
| Adjusted earnings | 3,535 |
| 0.03 |
| 120 |
| 0.00 |
|
(a) |
| Facility closure costs mainly related to the relocation of certain equipment from our held-for-sale Oxnard, California, frozen fruit processing facility to our Mexican facility, which were recorded in other expense. |
(b) |
| Represents third-party costs associated with business development activities, including costs related to the evaluation, execution, and integration of external acquisitions and divestitures, internal expansion projects, and other strategic initiatives. For the second quarter of 2022, these costs related to our inaugural Investor Day held in June 2022 ($0.5 million), as well as specific business transactions under consideration, which were recorded in SG&A expenses. For the second quarter of 2021, these costs were mainly related to the transition of the Dream and WestSoy brands, acquired in April 2021, and professional fees incurred in connection with post-closing matters related to the 2020 divestiture of our global ingredients business, Tradin Organic, which were recorded in SG&A expenses ($1.1 million) and other expense ($0.3 million). |
(c) |
| Represents incremental direct costs incurred in connection with plant expansion projects and new product introductions before the project or product reaches normal production levels, including costs for the hiring and training of additional personnel, fees for outside services, travel costs, and plant- and production-related expenses. For the second quarter of 2022, start-up costs mainly related to new employee hires for our plant-based beverage facility under construction in Midlothian, Texas, which were recorded in cost of goods sold ($0.2 million) and SG&A expenses ($0.1 million). |
(d) |
| For the second quarter of 2021, represents asset impairment charges and employee termination costs related to the exit from our South Gate, California, fruit ingredient processing facility, which were recorded in other expense. |
(e) |
| For the second quarters of 2022 and 2021, other mainly reflects the settlement of certain legal and contractual matters. |
(f) |
| Reflects the tax effect of the preceding adjustments to earnings calculated based on the statutory tax rates applicable in the tax jurisdiction of the underlying adjustment. |
|
|
|
|
|
|
|
|
|
| |||
|
|
|
|
| July 2, 2022 |
| July 3, 2021 | |||||
|
|
|
|
|
| Per Share |
|
| Per Share | |||
| For the two quarters ended | $ | $ |
| $ | $ | ||||||
| Earnings from continuing operations | 3,152 |
|
|
| 754 |
|
| ||||
| Dividends and accretion on preferred stock | (1,515 | ) |
|
| (2,697 | ) |
| ||||
| Earnings (loss) from continuing operations attributable to common shareholders | 1,637 |
| 0.02 |
| (1,943 | ) | (0.02 | ) | |||
| Adjusted for: |
|
|
|
|
| ||||||
|
| Facility closure costs(a) | 1,287 |
|
|
| - |
|
| |||
|
| Business development costs(b) | 799 |
|
|
| 1,786 |
|
| |||
|
| Start-up costs(c) | 721 |
|
|
| - |
|
| |||
|
| Costs related to exit from fruit ingredient processing facility(d) | - |
|
|
| 4,123 |
|
| |||
|
| Restructuring costs(e) | - |
|
|
| 1,432 |
|
| |||
|
| Other(f) | 540 |
|
|
| 247 |
|
| |||
|
| Net income tax effect(g) | (879 | ) |
|
| (4,262 | ) |
| |||
| Adjusted earnings | 4,105 |
| 0.04 |
| 1,383 |
| 0.01 |
|
(a) |
| Facility closure costs mainly related to the relocation of certain equipment from our held-for-sale Oxnard, California frozen fruit processing facility to our Mexican facility, which were recorded in other expense. |
(b) |
| Represents third-party costs associated with business development activities, including costs related to the evaluation, execution, and integration of external acquisitions and divestitures, internal expansion projects, and other strategic initiatives. For the first two quarters of 2022, these costs related to our inaugural Investor Day held in June 2022 ($0.5 million), as well as specific business transactions under consideration, which were recorded in SG&A expenses. For the first two quarters of 2021, these costs were mainly related to the transition of the Dream and WestSoy brands, acquired in April 2021, and professional fees incurred in connection with post-closing matters related to the 2020 divestiture of our global ingredients business, Tradin Organic, which were recorded in SG&A expenses ($1.3 million) and other expense ($0.5 million). |
(c) |
| Represents incremental direct costs incurred in connection with plant expansion projects and new product introductions before the project or product reaches normal production levels, including costs for the hiring and training of additional personnel, fees for outside services, travel costs, and plant- and production-related expenses. For the first two quarters of 2022, start-up costs mainly related to new employee hires for our plant-based beverage facility under construction in Midlothian, Texas, and the integration of the Dream and WestSoy brands, which were recorded in cost of goods sold ($0.6 million) and SG&A expenses ($0.1 million). |
(d) |
| For the first two quarters of 2021, represents asset impairment charges and employee termination costs related to the exit from our South Gate, California fruit ingredient processing facility, which were recorded in other expense. |
(e) |
| For the first two quarters of 2021, represents costs to complete the exit from our Santa Maria, California frozen fruit processing facility, which were recorded in other expense. |
(f) |
| For the first two quarters of 2022, other mainly reflects the settlement of certain legal and contractual matters, together with asset impairment charges. For the first two quarters of 2021, other mainly reflects the settlement of certain legal and contractual matters. |
(g) |
| Reflects the tax effect of the preceding adjustments to earnings calculated based on the statutory tax rates applicable in the tax jurisdiction of the underlying adjustment. |
Segment Operating Income and Adjusted EBITDA
The Company defines segment operating income as earnings from continuing operations before income taxes, interest expense and other income/expense items, and adjusted EBITDA as segment operating income plus depreciation, amortization, stock-based compensation, and other unusual items that affect the comparability of operating performance as identified above in the determination of adjusted earnings. The following is a tabular presentation of segment operating income and adjusted EBITDA, including a reconciliation to earnings from continuing operations, which the Company believes to be the most directly comparable U.S. GAAP financial measure.
|
|
|
|
| July 2, 2022 |
| July 3, 2021 | |
| For the quarter ended | $ |
| $ | ||||
| Earnings (loss) from continuing operations | 2,498 |
| (918 | ) | |||
| Income tax expense (benefit) | 939 |
| (3,651 | ) | |||
| Interest expense, net | 3,132 |
| 1,631 |
| |||
| Other expense, net | 1,540 |
| 4,661 |
| |||
| Total segment operating income | 8,109 |
| 1,723 |
| |||
|
| Depreciation and amortization | 9,372 |
| 8,910 |
| ||
|
| Stock-based compensation | 3,970 |
| 4,370 |
| ||
|
| Business development costs(a) | 616 |
| 1,143 |
| ||
|
| Start-up costs(b) | 281 |
| - |
| ||
| Adjusted EBITDA | 22,348 |
| 16,146 |
|
(a) |
| Business development activities were related to our Investor Day and the exploration of potential strategic opportunities in the second quarter of 2022, and the integration of the Dream and WestSoy brands in the second quarter of 2021, which costs were recorded in SG&A expenses. |
(b) |
| For the second quarter of 2022, start-up costs mainly related to new employee hires for our plant-based beverage facility under construction in Midlothian, Texas, which were recorded in cost of goods sold. |
|
|
|
|
| July 2, 2022 |
| July 3, 2021 | |
| For the two quarters ended | $ |
| $ | ||||
| Earnings from continuing operations | 3,152 |
| 754 |
| |||
| Income tax expense (benefit) | 1,384 |
| (2,513 | ) | |||
| Interest expense, net | 5,662 |
| 3,291 |
| |||
| Other expense, net | 1,827 |
| 6,276 |
| |||
| Total segment operating income | 12,025 |
| 7,808 |
| |||
|
| Depreciation and amortization | 18,785 |
| 16,953 |
| ||
|
| Stock-based compensation | 5,599 |
| 8,343 |
| ||
|
| Business development costs(a) | 799 |
| 1,312 |
| ||
|
| Start-up costs(b) | 721 |
| - |
| ||
| Adjusted EBITDA | 37,929 |
| 34,416 |
|
(a) |
| Business development activities were related to our Investor Day and the exploration of potential strategic opportunities in the first two quarters of 2022, and the integration of the Dream and WestSoy brands in the first two quarters of 2021, which costs were recorded in SG&A expenses. |
(b) |
| For the first two quarters of 2022, start-up costs mainly related to new employee hires for our plant-based beverage facility under construction in Midlothian, Texas, and the integration of the Dream and WestSoy brands acquired in April 2021, which were recorded in cost of goods sold. |
Last Trade: | US$7.81 |
Daily Change: | 0.02 0.26 |
Daily Volume: | 584,303 |
Market Cap: | US$912.520M |
November 05, 2024 October 09, 2024 September 18, 2024 September 16, 2024 August 07, 2024 |
Hillcrest Energy Technologies is a clean technology company developing high value, high performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable...
CLICK TO LEARN MOREElse Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS